Think you’re safe from shingles just because you’re young? Think again. Dive into the shocking reasons why the shingles vaccine isn’t universally recommended for those under 50, from FDA approval hurdles to the hidden economics of vaccine trials. Discover why older adults and immunocompromised individuals are prioritized, and uncover the risks of off-label use that could cost you more than just money. This eye-opening breakdown will leave you questioning everything you thought you knew about shingles prevention. For advertising opportunities, visit Avonetics.com.

Ver todos los episodios